UCB
Mythili Iyer currently serves as Senior Director of Corporate Strategy Analysis and Finance Lead at UCB, a position held since March 2024. Prior to this, Mythili Iyer held various roles at Lazard, including Vice President and Associate from July 2019 to March 2024. Earlier experience includes positions as Associate at Moelis & Company, Huron, and Merrill Lynch, along with a summer analyst role at Bank of America Merrill Lynch and internships at TIAA-CREF and Jet Propulsion Laboratory. Mythili Iyer began a research role at BioMedGPS, LLC, and has research experience at Princeton University. Educational background includes a Bachelor of Science degree from Caltech in Economics and Chemical Engineering, along with attendance at The Lawrenceville School and Princeton Day School.
This person is not in any teams
This person is not in any offices
UCB
45 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.